Neurotech International Ltd has released a press release.
Appendix 4E and Annual Report to Shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Quarterly Update & Appendix 4C
- Pause In Trading
- Quarterly Activities and Cashflow Report
- Response to ASX Price Query
- Dr Adrian Attard Trevisan
Later from Neurotech International
- Cancellation of Mente Device from Australian TGA Register
- Response to Appendix 4C Query
- Mente receives CE Mark renewal for use with ASD Children
- NTI Secures Option to Cannabis Strains Targeting Autism
- Neurotech Proceeds to in vitro trials after Positive Results
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International